Literature DB >> 31952963

Neutral analogs of the heat shock protein 70 (Hsp70) inhibitor, JG-98.

Hao Shao1, Jason E Gestwicki2.   

Abstract

The heat shock protein 70 (Hsp70) family of molecular chaperones are highly expressed in tumors. Inhibitors containing a pyridinium-modified benzothiazole, such as JG-98, bind to a conserved, allosteric site in Hsp70, showing promising anti-proliferative activity in cancer cells. When bound to Hsp70, the charged pyridinium makes favorable contacts; however, this moiety also increases the inhibitor's fluorescence, giving rise to undesirable interference in biochemical and cell-based assays. Here, we explore whether the pyridinium can be replaced with a neutral pyridine. We report that pyridine-modified benzothiazoles, such as compound 17h (JG2-38), have reduced fluorescence, yet retain promising anti-proliferative activity (EC50 values ~0.1 to 0.07 µM) in breast and prostate cancer cell lines. These chemical probes are expected to be useful in exploring the roles of Hsp70s in tumorigenesis and cell survival.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Allosteric inhibitor; Anti-cancer agents; Breast cancer; Chemical probe; Fluorescence; Molecular chaperone; Prostate cancer; Proteostasis

Mesh:

Substances:

Year:  2020        PMID: 31952963      PMCID: PMC7205417          DOI: 10.1016/j.bmcl.2020.126954

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  32 in total

1.  Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity.

Authors:  Sheara W Fewell; Christine M Smith; Michael A Lyon; Teodora Pene Dumitrescu; Peter Wipf; Billy W Day; Jeffrey L Brodsky
Journal:  J Biol Chem       Date:  2004-09-23       Impact factor: 5.157

2.  Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70).

Authors:  Hao Shao; Xiaokai Li; Michael A Moses; Luke A Gilbert; Chakrapani Kalyanaraman; Zapporah T Young; Margarita Chernova; Sara N Journey; Jonathan S Weissman; Byron Hann; Matthew P Jacobson; Len Neckers; Jason E Gestwicki
Journal:  J Med Chem       Date:  2018-07-13       Impact factor: 7.446

3.  Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function.

Authors:  R Wadhwa; T Sugihara; A Yoshida; H Nomura; R R Reddel; R Simpson; H Maruta; S C Kaul
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

4.  Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents.

Authors:  Xiaokai Li; Sharan R Srinivasan; Jamie Connarn; Atta Ahmad; Zapporah T Young; Adam M Kabza; Erik R P Zuiderweg; Duxin Sun; Jason E Gestwicki
Journal:  ACS Med Chem Lett       Date:  2013-11-14       Impact factor: 4.345

5.  Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding.

Authors:  Annette N Chiang; Mary Liang; Antonio Dominguez-Meijide; Caterina Masaracchia; Jennifer L Goeckeler-Fried; Carly S Mazzone; David W Newhouse; Nathan M Kendsersky; Megan E Yates; Alexandra Manos-Turvey; Patrick G Needham; Tiago F Outeiro; Peter Wipf; Jeffrey L Brodsky
Journal:  Bioorg Med Chem       Date:  2018-11-15       Impact factor: 3.641

6.  Pyrimidinone-peptoid hybrid molecules with distinct effects on molecular chaperone function and cell proliferation.

Authors:  Christine M Wright; Raj J Chovatiya; Nora E Jameson; David M Turner; Guangyu Zhu; Stefan Werner; Donna M Huryn; James M Pipas; Billy W Day; Peter Wipf; Jeffrey L Brodsky
Journal:  Bioorg Med Chem       Date:  2007-12-14       Impact factor: 3.641

7.  Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer.

Authors:  Michael A Moses; Yeong Sang Kim; Genesis M Rivera-Marquez; Nobu Oshima; Matthew J Watson; Kristin E Beebe; Catherine Wells; Sunmin Lee; Abbey D Zuehlke; Hao Shao; William E Bingman; Vineet Kumar; Sanjay V Malhotra; Nancy L Weigel; Jason E Gestwicki; Jane B Trepel; Leonard M Neckers
Journal:  Cancer Res       Date:  2018-05-15       Impact factor: 12.701

Review 8.  The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions.

Authors:  Mads Daugaard; Mikkel Rohde; Marja Jäättelä
Journal:  FEBS Lett       Date:  2007-05-25       Impact factor: 4.124

9.  Heat shock protein 70 inhibitors. 1. 2,5'-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides as irreversible binders to an allosteric site on heat shock protein 70.

Authors:  Yanlong Kang; Tony Taldone; Hardik J Patel; Pallav D Patel; Anna Rodina; Alexander Gozman; Ronnie Maharaj; Cristina C Clement; Maulik R Patel; Jeffrey L Brodsky; Jason C Young; Gabriela Chiosis
Journal:  J Med Chem       Date:  2014-02-18       Impact factor: 7.446

10.  Heat shock protein 70 inhibitors. 2. 2,5'-thiodipyrimidines, 5-(phenylthio)pyrimidines, 2-(pyridin-3-ylthio)pyrimidines, and 3-(phenylthio)pyridines as reversible binders to an allosteric site on heat shock protein 70.

Authors:  Tony Taldone; Yanlong Kang; Hardik J Patel; Maulik R Patel; Pallav D Patel; Anna Rodina; Yogita Patel; Alexander Gozman; Ronnie Maharaj; Cristina C Clement; Alvin Lu; Jason C Young; Gabriela Chiosis
Journal:  J Med Chem       Date:  2014-02-18       Impact factor: 7.446

View more
  5 in total

1.  A campaign targeting a conserved Hsp70 binding site uncovers how subcellular localization is linked to distinct biological activities.

Authors:  Hao Shao; Shuhei Taguwa; Luke Gilbert; Arielle Shkedi; Sara Sannino; Christopher J Guerriero; Zachary J Gale-Day; Zapporah T Young; Jeffrey L Brodsky; Jonathan Weissman; Jason E Gestwicki; Judith Frydman
Journal:  Cell Chem Biol       Date:  2022-07-12       Impact factor: 9.039

2.  Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.

Authors:  Ian D Ferguson; Yu-Hsiu T Lin; Christine Lam; Hao Shao; Kevin M Tharp; Martina Hale; Corynn Kasap; Margarette C Mariano; Audrey Kishishita; Bonell Patiño Escobar; Kamal Mandal; Veronica Steri; Donghui Wang; Paul Phojanakong; Sami T Tuomivaara; Byron Hann; Christoph Driessen; Brian Van Ness; Jason E Gestwicki; Arun P Wiita
Journal:  Cell Chem Biol       Date:  2022-07-18       Impact factor: 9.039

3.  Inhibitors of heat shock protein 70 (Hsp70) with enhanced metabolic stability reduce tau levels.

Authors:  Hao Shao; Xiaokai Li; Shigenari Hayashi; Jeanette L Bertron; Daniel M C Schwarz; Benjamin C Tang; Jason E Gestwicki
Journal:  Bioorg Med Chem Lett       Date:  2021-04-09       Impact factor: 2.940

Review 4.  Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms.

Authors:  Steven De Almeida; Mathilde Regimbeau; Gaëtan Jego; Carmen Garrido; François Girodon; François Hermetet
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639

Review 5.  HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy.

Authors:  Alexander E Kabakov; Vladimir L Gabai
Journal:  Cells       Date:  2021-12-07       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.